Vaxart, Inc.

VXRTCIK 0000072444 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone 0.0012

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 19, 2026no items parsed May 7, 2026no items parsed Apr 23, 20265.02 · Departure/Election7.01 · Regulation FD Disclosure9.01 · Financial Statements and Exhibits Apr 21, 2026no items parsed Apr 17, 2026no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Vaxart, Inc.

Name	Roles	Filings
Wheadon David E.	Director	3
Floroiu Cezar Andrei	OfficerDirector	2
Yedid Robert A.	Director	2
Ahmad Fuad	Officer	1
Breitmeyer James B	Director	1

Showing 11-15 of 15

Per pagePrevPage 3 of 3

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Vaxart, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#	Insider	Trades	Win rate	Avg	Median	Best	Worst
1	Watson W. Mark	4	75%	+28.9%	+40.9%	+43.6%	-10.0%
2	Finney Kevin	6	0%	-6.7%	-7.7%	0.0%	-12.5%

All filings

83 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
May 26, 2026	Watson W. Mark Director	PPurchase	10,000	$0.653	$6,530
May 21, 2026	Grasman Jeroen Nicolaas Chief Financial Officer	FTax	31,395	$0.61	$19,151
May 1, 2026	Breitmeyer James B Director	AGrant	78,800	$0.00	$0
Mar 31, 2026	Cummings James F. Chief Medical Officer	FTax	3,292	$0.65	$2,140
Mar 31, 2026	Tucker Sean SVP, Chief Scientific Officer	FTax	3,924	$0.65	$2,551

Showing 1-5 of 83

Per pagePage 1 of 17Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value